Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CYRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.58 - $20.11
Previous CloseN/A
Volume42.91K
Average Volume (3M)486.48K
Market Cap
$283.99M
Enterprise Value$409.25M
Total Cash (Recent Filing)$45.29M
Total Debt (Recent Filing)$250.70M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
May 01, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.49
Shares Outstanding49,910,393
10 Day Avg. Volume707,064
30 Day Avg. Volume486,476
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.24
Price to Cash Flow (P/CF)-13.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.11
Enterprise Value/Ebitda-5.21
Forecast
1Y Price Target
$10.92Price Target Upside91.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
Bulls Say, Bears Say
Bulls Say
Operational EfficiencyCryoPort reported a significant improvement in gross margins due to increased profitability in Life Sciences Services and cost-saving actions.
Revenue GrowthLife Science Services revenue increased by 7% driven by healthy growth in both BioLogistics Solutions and BioStorage/BioServices and included significant CGT commercial revenue growth.
Bears Say
Healthcare Market RisksSignificant uncertainty remains in the healthcare market due to tariffs, China tensions, and turnover at FDA and NIH, which could drive downside risks.
Market UncertaintyBroader pharmaceutical uncertainty, along with NIH and FDA changes, keep the stock at an equal weight rating despite the recent pullback.
---
Ownership Overview
2.65% Insiders
18.54% Mutual Funds
36.53% Other Institutional Investors
24.45% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $4.58 and its highest was $20.11 in the past 12 months.
What is CryoPort Inc’s market cap?
CryoPort Inc’s market cap is $283.99M.
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is May 01, 2025 which is in 38 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Mar 04, 2025. The company reported -$0.42 earnings per share for the quarter, missing the consensus estimate of -$0.293 by -$0.127.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -0.33.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 49,910,393 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.42 in its last earnings report, missing expectations of -$0.293. Following the earnings report the stock price went up 30.632%.
Which hedge fund is a major shareholder of CryoPort Inc?
Currently, no hedge funds are holding shares in CYRX
---
CryoPort Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.92 (91.92% Upside)
$10.92 (91.92% Upside)
Blogger Sentiment
Bearish
CYRX Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 72.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $59.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.8%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.55%
12-Months-Change
Fundamentals
Return on Equity
-25.76%
Trailing 12-Months
Asset Growth
-26.55%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
---
CYRX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue performance, particularly in the Life Sciences Services business and commercial revenue growth. The company achieved significant improvements in gross margin and is optimistic about future revenue growth and profitability in 2025. However, macroeconomic challenges and concerns over the China market were noted as lowlights.Read More>---
CYRX Stock 12 Month Forecast
Average Price Target
$10.92
▲(91.92% Upside)
Technical Analysis
Charles River Labs
―
Icon
―
Perrigo Company
―
Sarepta Therapeutics
―
BioLife Solutions
―
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+38.68%
reiterated a buy rating 20 days ago
Copying Richard Baldry's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +38.68% per trade.
---